Items tagged with Treatment
South Africa: the country where political leadership serves the people (post)
In an unprecedented and historic move, South African Department of Health decided to recommend including bedaquiline as the standard treatment for patients with drug-resistant TB (DR-TB). The country also released data showing that treatment regimens including bedaquiline reduced mortality three-fold compared with those without bedaquiline.
Kanchan Mukherjee: Bedaquiline for multidrug-resistant TB in India — at what cost? (post)
In a blog post in The BMJ Opinion, Kanchan Mukherjee, a medical doctor and professor at the Tata Institute of Social Sciences in Mumbai, discusses the potential benefits and challenges of a wider government rollout of bedaquiline to treat multidrug-resistant TB in India.
Isoniazid-rifapentine for latent TB infection: a systematic review and meta-analysis (post)
A review published in the American Journal of Preventive Medicine examined the most recent evidence regarding 3-month isoniazid-rifapentine’s effectiveness, safety, and treatment completion when directly compared with other latent TB infection regimens primarily comprising 9-month isoniazid treatment.
Higher doses of rifampin appear more effective in fighting TB without increasing risk of adverse events (post)
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
CDC releases updated recommendations for treatment of latent TB infection (post)
The U.S. Centers for Disease Control and Prevention (CDC) has issued updated recommendations regarding the use of 3HP (once-weekly isoniazid-rifapentine for 12 weeks) for the treatment of latent tuberculosis (TB) infection.
From decades to days: 3D modelling tuberculosis (post)
3D modelling of the mutations in TB means doctors around the world could soon tailor individual treatments for the disease in a matter of days, rather than years.
The 'hell' of fighting drug-resistant TB causes some to abandon treatment (post)
ESHOWE, South Africa — Canadian Press reporters travelled to South Africa and India to investigate the growing epidemic of drug resistance, which experts describe as the single greatest threat to human health on the planet. This is the fifth story of a six-part series exploring how the unfettered use of antibiotics pushes humanity closer to a post-antibiotic era in which common infections may be impossible to treat. The R. James Travers Foreign Corresponding Fellowship helped fund the project.
South African TB study finds lower death rate with bedaquiline (post)
In a study that could have an impact on the treatment of drug-resistant tuberculosis (TB), a team of South African researchers report that the novel TB drug bedaquiline was associated with a significant reduction in mortality for patients with multidrug-resistant (MDR), rifampicin-resistant, and extensively drug-resistant (XDR) strains of the infection.
South Africa ensures reduction of prices for bedaquiline to benefit the world (post)
The cost of bedaquiline drops to 400 USD/6-month treatment course, effective immediately and will be made available for all TB programs procuring from the Stop TB Partnership’s Global Drug Facility (GDF).
Union working group show crucial link between TB and mental health (post)
The Union’s TB and Mental Health Working Group have released a video, Learning from the field: the mental health management of MDR-TB in Peru, to promote the wide-scale provision of mental health screening and services for patients receiving treatment for tuberculosis (TB) worldwide.
Page 40 of 108 · Total posts: 0
←First 39 40 41 Last→